What is Gilead Sciences's allowance for doubtful accounts?

Gilead Sciences (GILD) reported allowance for doubtful accounts of $44M in Q1 2026.

How has Gilead Sciences's allowance for doubtful accounts changed year-over-year?

Gilead Sciences's allowance for doubtful accounts decreased by 25.4% year-over-year, from $59M to $44M.

What is the long-term trend for Gilead Sciences's allowance for doubtful accounts?

Over 5 years (2020 to 2025), Gilead Sciences's allowance for doubtful accounts has grown at a -1.4% compound annual growth rate (CAGR), from $44M to $41M.

Gilead Sciences GILD Allowance for doubtful accounts

Allowance for doubtful accounts at other companies

ImmunityBio, Inc.IBRX

——

PrecigenPGEN

——

Merck & Co.MRK

——

Other financials

Income statement

See full

Revenue$7.0B+4.4%

Gross profit$5.5B+7.6%

Operating income$2.6B+15.6%

Net income$2.0B+53.7%

EPS (diluted)$1.61+54.8%

Balance sheet

See full

Cash & equivalents$7.6B-3.8%

Total debt$22.2B-11.1%

Total equity$23.5B+22.7%

Total assets$56.3B-0.3%

Cash flow

See full

Operating cash flow$2.5B+44.8%

CapEx$117.0M+12.5%

Free cash flow$2.4B+46.8%

Valuation

See full

Market cap$156.86B+21.7%

Enterprise value$171.41B+15.5%

P/E17×-3.4×

P/S5.3×+0.8×

Profitability

See full

Gross margin79.4%+1.1pp

Operating margin34.9%+6.3pp

Net margin31%+10.2pp

FCF margin34.4%+0.1pp

Returns & leverage

See full

Return on equity43.2%+10.7pp

Debt / equity0.9×-0.4×

Current ratio2×+0.6×

Where this comes from

Reported directly by Gilead Sciences in its filing.

Tagged under the XBRL concept us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent.

The official record: Gilead Sciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gilead Sciences's allowance for doubtful accounts.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Gilead Sciences's allowance for doubtful accounts?: Gilead Sciences (GILD) reported allowance for doubtful accounts of $44M in Q1 2026.
How has Gilead Sciences's allowance for doubtful accounts changed year-over-year?: Gilead Sciences's allowance for doubtful accounts decreased by 25.4% year-over-year, from $59M to $44M.
What is the long-term trend for Gilead Sciences's allowance for doubtful accounts?: Over 5 years (2020 to 2025), Gilead Sciences's allowance for doubtful accounts has grown at a -1.4% compound annual growth rate (CAGR), from $44M to $41M.